Pulmonary toxicity of drugs used to treat systemic autoimmune diseases. Review uri icon

Overview

abstract

  • A number of drugs used to treat systemic autoimmune diseases can cause respiratory complications. These include bronchospasm, noncardiac pulmonary edema, interstitial pneumonitis and fibrosis, hypersensitivity, and numerous other disorders. Additionally, some of these drugs increase the risk of infections, particularly with opportunistic organisms. This article reviews the clinical presentation and mechanism of toxicity of drug related pulmonary complications.

publication date

  • December 1, 1998

Research

keywords

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antirheumatic Agents
  • Autoimmune Diseases
  • Lung Diseases

Identity

Scopus Document Identifier

  • 0032424897

Digital Object Identifier (DOI)

  • 10.1016/s0272-5231(05)70118-0

PubMed ID

  • 9917966

Additional Document Info

volume

  • 19

issue

  • 4